uniQure (QURE) EBITDA Margin (2016 - 2026)
uniQure (QURE) posted EBITDA Margin of 893.73% for Q2 2026, up 30.37% on a QoQ basis from 1283.55% in Q1 2026, and down 6012.0% year-over-year from 15.12% in Q2 2025.
Powered by 
Analysis
uniQure (QURE) EBITDA Margin (2016 - 2026) Analysis & Trends
uniQure has reported EBITDA Margin for 11 years, with the latest figure at 893.73% in Q2 2026.
- On a quarterly basis, EBITDA Margin fell 6012.0% year-over-year to 893.73% in Q2 2026; TTM through Jun 2026 was 1071.53%, a 10900.0% increase from a year earlier, with the FY2025 full-year figure at 1151.38%, down 51842.0% from the prior year.
- EBITDA Margin was 893.73% for Q2 2026 at uniQure, up from 1283.55% in the prior quarter.
- The five-year high for EBITDA Margin was 25.79% in Q4 2022, with the low at 11279.88% in Q2 2022.
- Average EBITDA Margin over 5 years is 2260.6%, with a median of 1331.25% recorded in 2025.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin tumbled 1136568 bps in 2022, then soared 859309 bps in 2023.
- Over 5 years, EBITDA Margin stood at 25.79% in 2022, then plunged by 3679 bps to 923.13% in 2023, then climbed by 5 bps to 877.76% in 2024, then slipped by 5 bps to 918.07% in 2025, then rose by 3 bps to 893.73% in 2026.
- The last three EBITDA Margin figures came in at 893.73% (Q2 2026), 1283.55% (Q1 2026), and 918.07% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 37.40% |
| 10 | uniQure | 2.96 Bn | 2.96 Bn | 5.49 Mn | -893.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -893.73% |
| Mar 31, 2026 | -1,283.55% |
| Dec 31, 2025 | -918.07% |
| Sep 30, 2025 | -1,378.95% |
| Jun 30, 2025 | -833.62% |
| Mar 31, 2025 | -2,509.96% |
| Dec 31, 2024 | -877.76% |
| Sep 30, 2024 | -1,758.99% |
| Jun 30, 2024 | -395.56% |
| Mar 31, 2024 | -639.10% |
| Dec 31, 2023 | -923.13% |
| Sep 30, 2023 | -5,819.26% |
| Jun 30, 2023 | -2,686.79% |
| Mar 31, 2023 | -1,392.90% |
| Dec 31, 2022 | 25.79% |
| Sep 30, 2022 | -4,107.52% |
| Jun 30, 2022 | -11,279.88% |
| Mar 31, 2022 | -3,017.86% |
| Dec 31, 2021 | 3.58% |
| Sep 30, 2021 | -2,262.44% |
API Access
uniQure EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=QURE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "QURE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=QURE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();